Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia
FDA is expected to assign a Prescription Drug User Fee Act (PDUFA) target action date and announce whether Priority Review has been granted in ...
Offering hope for people facing chronic pain
A major breakthrough in our understanding of pain has been revealed in a collaborative study, opening the door to new ways of tackling long term pain without harmful and addictive opioids.
Armed robbery in Revesby16h
New Insights Unveil Potassium Channel Mechanisms
Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin, the University of Kiel, and the Leibniz Institute of ...
Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition
A vision-threatening eye condition may be linked to Ozempic. Meanwhile, Nearly 80% of doctors are using telemedicine weekly, ...
Endocrinology Advisor14h
FDA Drug Approval Decisions Expected in January 2025
Therapies for EBV-positive posttransplant lymphoproliferative disease, breast cancer, Barth syndrome, pain, and migraine are under review.
Top five PIP health conditions paying millions of people up to £737 each month
The new data also indicates some 37 per cent of all claimants are receiving the highest rates of PIP for both the daily ...
Chamberlain Sun21h
Gluco6 Reviews: Does It Really Work for Blood Sugar Control? Here’s My Experience!
Discover the truth in these Gluco6 reviews – does this popular supplement actually help manage blood sugar, or is it too good ...